Article Versions Notes

Wu Y, Xu M-J, Cao Z, Yang C, Wang J, Wang B, Liu J, Wang Y, Xian X, Zhang F, et al. Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis. International Journal of Molecular Sciences. 2019; 20(23):5936. https://doi.org/10.3390/ijms20235936

Wu, Yue, Ming-Jiang Xu, Zhiyou Cao, Chun Yang, Jinjie Wang, Bijue Wang, Jian Liu, Yuhui Wang, Xunde Xian, Fang Zhang, and et al. 2019. "Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis" International Journal of Molecular Sciences 20, no. 23: 5936. https://doi.org/10.3390/ijms20235936

Wu, Y., Xu, M.-J., Cao, Z., Yang, C., Wang, J., Wang, B., Liu, J., Wang, Y., Xian, X., Zhang, F., Liu, G., & Chen, X. (2019). Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis. International Journal of Molecular Sciences, 20(23), 5936. https://doi.org/10.3390/ijms20235936